Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

38.2K
The Concept of Multiple Allelism
38.2K
Multiple Regression01:25

Multiple Regression

4.0K
Multiple regression assesses a linear relationship between one response or dependent variable and two or more independent variables. It has many practical applications.
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
4.0K
Multiple Voltage Sources01:25

Multiple Voltage Sources

1.8K
Generally, a single battery is not enough to power some devices. In such cases, batteries can be combined in two ways: in series or in parallel.
In series, the positive terminal of one battery is connected to the negative terminal of another battery. Hence, the voltage of each battery is added to give the net voltage, which is increased because each battery boosts the electrons that enter it. The same current flows through each battery because they are connected in series.
Batteries are...
1.8K
Deformation of Member under Multiple Loadings01:11

Deformation of Member under Multiple Loadings

484
When a rod is made of different materials or has various cross-sections, it must be divided into parts that meet the necessary conditions for determining the deformation. These parts are each characterized by their internal force, cross-sectional area, length, and modulus of elasticity. These parameters are then used to compute the deformation of the entire rod.
In the case of a member with a variable cross-section, the strain is not constant but depends on the position. The deformation of an...
484
Multiple Bar Graph01:07

Multiple Bar Graph

10.1K
As the name suggests, a multiple bar graph is the same as a bar graph but has multiple bars to depict relationships between different data values. One can include as many parameters as possible. However, each parameter must have the same unit of measurement.
Each bar or column in the multiple bar graph represents a data value. These graphs are used primarily in interrelating two or more sets of data. The categories of different kinds of data are listed along the horizontal or x-axis, whereas...
10.1K
Multiple Comparison Tests01:13

Multiple Comparison Tests

4.5K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward a cure for multiple myeloma within a decade.

Blood cancer journal·2026
Same author

Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025.

European journal of haematology·2026
Same author

35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

Blood cancer journal·2025
Same author

Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience.

Bone marrow transplantation·2025
Same author

Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma.

Blood advances·2025
Same author

Precision medicine for multiple myeloma: The case for translocation (11;14).

Cancer treatment reviews·2024

Related Experiment Video

Updated: Feb 7, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.8K

Multiple myeloma.

Jean-Luc Harousseau1, John Shaughnessy, Paul Richardson

  • 1Hotel Dieu, Nantes, France.

Hematology. American Society of Hematology. Education Program
|November 25, 2004
PubMed
Summary

Gene expression profiling identifies multiple myeloma (MM) subgroups and predicts relapse. Novel agents and intensive therapies like autologous stem cell transplantation (ASCT) improve outcomes, but further research is needed for aggressive disease.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Multiple myeloma (MM) cells often develop resistance to conventional therapies.
  • High-dose therapy with stem cell transplantation (SCT) and novel targeted agents offer improved treatment strategies.
  • Gene expression profiling (GEP) aids in identifying prognostic subgroups and molecular targets in MM.

Purpose of the Study:

  • To review recent advancements in multiple myeloma treatment, focusing on gene expression profiling, intensive therapies, and novel targeted agents.
  • To highlight the prognostic power of GEP and identify key genes associated with rapid relapse.
  • To summarize the efficacy and ongoing research of autologous SCT (ASCT) and reduced-intensity conditioning (RIC) allogeneic SCT, alongside novel targeted therapies.

Main Methods:

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K

Related Experiment Videos

Last Updated: Feb 7, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.8K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K
  • Gene expression profiling (GEP) of CD138-purified plasma cells from MM patients.
  • Analysis of clinical data and outcomes from tandem autologous SCT (ASCT) and reduced-intensity conditioning (RIC) allogeneic SCT trials.
  • Review of preclinical and clinical data for novel targeted therapies including thalidomide analogues and bortezomib.

Main Results:

  • GEP identified four MM subgroups correlated with clinical characteristics, outcomes, and cytogenetic abnormalities.
  • Overexpression of DKK1 by MM cells contributes to osteolytic bone lesions.
  • Abnormal expression of three genes (RAN, ZHX-2, CHC1L) is linked to rapid relapses, offering a more powerful prognostic model than standard methods.
  • Double ASCT is superior to single ASCT for event-free survival in MM patients up to 65 years.
  • Novel agents like thalidomide, IMiDs, and bortezomib show promise in overcoming drug resistance and improving outcomes in relapsed/refractory MM.

Conclusions:

  • GEP provides a powerful tool for prognostication and identifying therapeutic targets in MM.
  • Tandem ASCT improves outcomes but may not benefit patients with poor prognostic features.
  • Novel targeted therapies are crucial for improving MM treatment, particularly in relapsed or refractory cases.
  • Further research and longer follow-up are needed to clarify the role of RIC allogeneic SCT and optimize combination therapies.